Signant’s clinical research technology solutions and services improve major depressive disorder studies to faciliate the development of new treatment and therapies for patients everywhere.

Get details on how Signant helps improve study success in these ways:

• Address rater scoring inconsistencies or inaccuracies
• Employ proactive data analytics to monitor data quality through the study
• Simplify participation with tailored eCOA
• Improve patient comprehension of study requirements as well as ICF document management

Look inside for our MDD study experience and therapeutic area experts.